Batanopride
Batanopride (BMY-25,801) is an antiemetic drug of the benzamide class which acts as a selective 5-HT3 receptor antagonist. It was trialled to reduce nausea during cancer chemotherapy, but was never approved for medical use due to dose-limiting side effects including hypotension and long QT syndrome.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Batanopride
Batanopride (BMY-25,801) is an antiemetic drug of the benzamide class which acts as a selective 5-HT3 receptor antagonist. It was trialled to reduce nausea during cancer chemotherapy, but was never approved for medical use due to dose-limiting side effects including hypotension and long QT syndrome.
has abstract
Batanopride (BMY-25,801) is an ...... otension and long QT syndrome.
@en
CAS number
102670-46-2
ChEMBL
FDA UNII code
1AT99K728N
PubChem
Wikipage page ID
26,522,874
page length (characters) of wiki page
Wikipage revision ID
963,671,910
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChEMBL
ChemSpiderID
IUPAC name
legal status
Uncontrolled
@en
PubChem
routes of administration
Oral
@en
SMILES
Clc1ccCNCCNCC
@en
StdInChIKey
ZYOJXUNLLOBURP-UHFFFAOYSA-N
@en
Verifiedfields
changed
@en
verifiedrevid
461,752,878
Watchedfields
changed
@en
wikiPageUsesTemplate
hypernym
comment
Batanopride (BMY-25,801) is an ...... otension and long QT syndrome.
@en
label
Batanopride
@en